Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


The implication of monitoring tumour markers: a personalised medicine approach

  • In: Poster presentation
  • At: Seoul (South Korea) (2017)
  • Type: Poster
  • Poster code: POS-HPS-003
  • By: GRECH, Louise (University of Malta, Pharmacy, Attard, Malta)
  • Co-author(s): Charyl Fava: Pharmacy, University of Malta, Msida, Malta
    Louise Grech: Pharmacy, University of Malta, Msida, Malta;Pharmacy, Mater Dei Hospital, Msida, Malta
    Rachel Micallef: Oncology, Sir Anthony Mamo Oncology Centre, Msida, Malta
    Stefan Laspina: Haematology and Oncology, Mater Dei Hospital, Msida, Malta
    Christopher Barbara: Pathology, Mater Dei Hospital, Msida, Malta
    Lilian M. Azzopardi: Pharmacy, University of Malta, Msida, Malta
  • Abstract:

    Background

    The availability of tumour markers in managing oncology patients contributes to developing personalised pharmacotherapy. 

    Purpose

    To develop and implement a pharmaceutical personalised approach based on harmaceutical care plan (PCP) incorporating tumour markers for patients suffering from ovarian, pancreatic or prostate cancer.

    Methods

    Drug

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses